On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Foreign Ownership Restrictions Eased in the Canadian Aviation Sector
With the Transportation Modernization Act (Bill C-49) receiving Royal Assent on May 23, 2018, the longstanding restriction on foreign ownership in the Canadian aviation sector ... Continued
Areet Kaila article republished in The Legal Edge
If you are negotiating a contract, you should read Areet Kaila’s article entitled, “The Accidental Contract?“. This article has recently been republished by The Legal ... Continued
David Austin interviewed by The Vancouver Sun
Yesterday, David Austin was interviewed by The Vancouver Sun on the subject of the growing tech-sector demand for green power. In the article, David states ... Continued